Abstract:Summary
Archaeal and eukaryotic translation elongation factor 2 contain a unique posttranslationally modified histidine residue called “diphthamide”, the target of diphtheria toxin. The biosynthesis of diphthamide were proposed to involve three steps, with the first step being the formation of a C-C bond between the histidine residue and the 3-amino-3-carboxypropyl group of S-adenosylmethionine (SAM). However, details of the biosynthesis have remained unknown. Here we present structural and biochemical evidenc… Show more
“…Resistance-There are six proteins required for diphthamide biosynthesis: DPH1-5 and WDR85 (10,11,20). Using RT-PCR, we measured the level of the mRNA for each of these proteins and found that the level of WDR85 mRNA was extremely low in CA46-R cells (Fig.…”
Section: Reduced Wdr85 Expression In the Ca46-r Cell Line Is Responsimentioning
Background: Some children with leukemia do not respond to an immunotoxin containing Pseudomonas exotoxin A.
Results:We isolated a resistant cell line and showed that a WDR85 gene deletion causes immunotoxin resistance by allowing formation of diphthamide containing an extra methyl group. Conclusion: Low WDR85 expression can cause immunotoxin resistance in patients. Significance: Analysis of EF2 may reveal why some patients fail therapy.
“…Resistance-There are six proteins required for diphthamide biosynthesis: DPH1-5 and WDR85 (10,11,20). Using RT-PCR, we measured the level of the mRNA for each of these proteins and found that the level of WDR85 mRNA was extremely low in CA46-R cells (Fig.…”
Section: Reduced Wdr85 Expression In the Ca46-r Cell Line Is Responsimentioning
Background: Some children with leukemia do not respond to an immunotoxin containing Pseudomonas exotoxin A.
Results:We isolated a resistant cell line and showed that a WDR85 gene deletion causes immunotoxin resistance by allowing formation of diphthamide containing an extra methyl group. Conclusion: Low WDR85 expression can cause immunotoxin resistance in patients. Significance: Analysis of EF2 may reveal why some patients fail therapy.
“…Diphthamide modification on eukaryotic translation elongation factor 2 (EF2) in budding yeast operates through a multi-step pathway. The diphthamide pathway, modified after Zhang et al (2010), involves known and elusive (?) steps with the intermediates 2-(3-carboxyl-3-aminopropyl)-histidine and diphthine being generated.…”
Section: Posttranslational Biosynthesis Of Diphthamide On Ef2mentioning
“…The second step is a trimethylation reaction to form diphthine, which is catalyzed by a single methyltransferase DPH5. Both the first and second steps have been reconstituted in vitro using purified proteins from a thermophilic archaea, Pyrococcus horikoshii (10)(11)(12). The third step is the amidation of diphthine to form diphthamide.…”
Many genes are of unknown functions in any sequenced genome. A combination of chemical and genetic perturbations has been used to investigate gene functions. Here we present a case that such "chemogenomics" information can be effectively used to identify missing genes in a defined biological pathway. In particular, we identified the previously unknown enzyme diphthamide synthetase for the last step of diphthamide biosynthesis. We found that yeast protein YLR143W is the diphthamide synthetase catalyzing the last amidation step using ammonium and ATP. Diphthamide synthetase is evolutionarily conserved in eukaryotes. The previously uncharacterized human gene ATPBD4 is the ortholog of yeast YLR143W and fully rescues the deletion of YLR143W in yeast.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.